Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 3, Pages 590
Publisher
MDPI AG
Online
2020-03-06
DOI
10.3390/cancers12030590
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Visible Co-delivery Nanovaccine of Antigen and Adjuvant with Self-carrier for Cancer Immunotherapy
- (2019) Xia Dong et al. ACS Applied Materials & Interfaces
- First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
- (2019) Neeta Somaiah et al. CLINICAL CANCER RESEARCH
- Antigen structure affects cellular routing through DC-SIGN
- (2019) Cassie M. Jarvis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection
- (2019) Jake William Rhodes et al. Frontiers in Immunology
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- Supplementary granulocyte macrophage colony‐stimulating factor to chemotherapy and programmed death‐ligand 1 blockade decreases local recurrence after surgery in bladder cancer
- (2019) Makito Miyake et al. CANCER SCIENCE
- Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies
- (2019) Courtney A. Iberg et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells
- (2019) Julia Volckmar et al. VACCINE
- Best practices for bioinformatic characterization of neoantigens for clinical utility
- (2019) Megan M. Richters et al. Genome Medicine
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells
- (2018) Marthe F.S. Lindenbergh et al. Annual Review of Immunology
- Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
- (2018) Tessa Gargett et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Advances in the Development of Anticancer HSP-based Vaccines
- (2018) Alexey V. Baldin et al. CURRENT MEDICINAL CHEMISTRY
- Human dendritic cell subset 4 (DC4) correlates to a subset of CD14 dim/− CD16 ++ monocytes
- (2018) Federica Calzetti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy
- (2018) Bijun Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Dendritic Cell–Based Cancer Vaccines
- (2018) Patricia M. Santos et al. JOURNAL OF IMMUNOLOGY
- Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma
- (2018) Larisa J. Geskin et al. MELANOMA RESEARCH
- Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells
- (2018) Long Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
- (2018) Arjan A. van de Loosdrecht et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
- (2018) Jhanelle E. Gray et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Personalized cancer neoantigen vaccines come of age
- (2018) Yanhong Chu et al. Theranostics
- Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma
- (2018) Alexey V. Baldin et al. BIOCHIMIE
- Dendritic cell-based immunotherapy: a basic review and recent advances
- (2017) João Constantino et al. IMMUNOLOGIC RESEARCH
- Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines
- (2017) Dieke van Dinther et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Transcriptional profiling reveals functional dichotomy between human slan+non-classical monocytes and myeloid dendritic cells
- (2017) Nathalie van Leeuwen-Kerkhoff et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Enhanced Spacer Length between Mannose Mimicking Shikimoyl and Quinoyl Headgroups and Hydrophobic Region of Cationic Amphiphile Increases Efficiency of Dendritic Cell Based DNA Vaccination: A Structure–Activity Investigation
- (2017) Chandrashekhar Voshavar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
- (2017) Isabelle Rivière et al. MOLECULAR THERAPY
- Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues
- (2017) D Sichien et al. Mucosal Immunology
- CD4/CD8/Dendritic cell complexes in the spleen: CD8+ T cells can directly bind CD4+ T cells and modulate their response
- (2017) Aleksandr Barinov et al. PLoS One
- Human Tumor Antigens Yesterday, Today, and Tomorrow
- (2017) Olivera J. Finn Cancer Immunology Research
- Role of Distinct Natural Killer Cell Subsets in Anticancer Response
- (2017) Helena Stabile et al. Frontiers in Immunology
- Trial watch: Dendritic cell-based anticancer immunotherapy
- (2017) Abhishek D. Garg et al. OncoImmunology
- Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
- (2017) Hae-Young Park et al. npj Vaccines
- Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
- (2016) Yuan Qian et al. BIOMATERIALS
- Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells
- (2016) Mariana Pereira Pinho et al. CYTOTHERAPY
- CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses
- (2016) Tim J. A. Hutten et al. JOURNAL OF IMMUNOLOGY
- Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response
- (2016) Arup Garu et al. MOLECULAR THERAPY
- Diversity and collaboration for effective immunotherapy
- (2016) Karolina Palucka et al. NATURE MEDICINE
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Tolerogenic dendritic cells
- (2016) Maisa C. Takenaka et al. Seminars in Immunopathology
- Dendritic cells as gatekeepers of tolerance
- (2016) Ari Waisman et al. Seminars in Immunopathology
- The cancer-retina antigen recoverin as a potential biomarker for renal tumors
- (2016) Marina O. Golovastova et al. TUMOR BIOLOGY
- A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
- (2016) Zhongyi Yan et al. Oncotarget
- Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants
- (2016) Angela Berzi et al. Scientific Reports
- Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer
- (2016) X. X. Wei et al. Cancer Immunology Research
- Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells
- (2016) Wenjie Yin et al. EBioMedicine
- Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment
- (2015) Robert O. Dillman et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
- (2015) G. Schreibelt et al. CLINICAL CANCER RESEARCH
- Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice
- (2015) L. Savvateeva et al. CURRENT MOLECULAR MEDICINE
- Emerging roles for scavenger receptor SREC-I in immunity
- (2015) Ayesha Murshid et al. CYTOKINE
- Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates
- (2015) Jessica Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
- (2015) B S Sundarasetty et al. GENE THERAPY
- The impact of dendritic cell–tumor fusion cells on cancer vaccines - past progress and future strategies
- (2015) Mikio Kajihara et al. Immunotherapy
- Mannosylated Polyion Complexes for In Vivo Gene Delivery into CD11c+ Dendritic Cells
- (2015) Lior Raviv et al. MOLECULAR PHARMACEUTICS
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
- (2015) Jeetendra Kumar et al. Stem Cell Research & Therapy
- Effective Targeting of DC-SIGN by α-Fucosylamide Functionalized Gold Nanoparticles
- (2014) Daniela Arosio et al. BIOCONJUGATE CHEMISTRY
- Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
- (2014) Sofie Wilgenhof et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
- (2014) Sandra Van Lint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine
- (2014) Li-Zhen He et al. Cellular & Molecular Immunology
- Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
- (2014) Gianfranco Picco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic cell specific targeting of MyD88 signalling pathways in vivo
- (2014) Catharina Arnold-Schrauf et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human Dermal CD14 + Cells Are a Transient Population of Monocyte-Derived Macrophages
- (2014) Naomi McGovern et al. IMMUNITY
- Hsp90–peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I
- (2014) Ayesha Murshid et al. IMMUNOBIOLOGY
- Antigen Delivery to CD11c+CD8- Dendritic Cells Induces Protective Immune Responses against Experimental Melanoma in Mice In Vivo
- (2014) K. Neubert et al. JOURNAL OF IMMUNOLOGY
- Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells
- (2014) Venetia Bigley et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- The Scavenger Receptor MARCO Modulates TLR-Induced Responses in Dendritic Cells
- (2014) Haydn T. Kissick et al. PLoS One
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
- (2013) Michael A. Morse et al. ANNALS OF SURGERY
- DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
- (2013) Jun Cao et al. BMC IMMUNOLOGY
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
- (2013) Elodie Segura et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Modulation of Regulatory T Cell Function by Monocyte-Derived Dendritic Cells Matured through Electroporation with mRNA Encoding CD40 Ligand, Constitutively Active TLR4, and CD70
- (2013) J. J. Pen et al. JOURNAL OF IMMUNOLOGY
- Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion
- (2013) J. Tel et al. JOURNAL OF IMMUNOLOGY
- Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma
- (2013) Ben C. Creelan et al. JOURNAL OF IMMUNOTHERAPY
- Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic Cells
- (2013) Semih U Tareen et al. MOLECULAR THERAPY
- Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells
- (2013) Scott Barbuto et al. Nature Chemical Biology
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain
- (2013) Karien Bloem et al. PLoS One
- Extracellular Heat Shock Proteins
- (2013) Antonio De Maio et al. SHOCK
- The Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes Human Plasmacytoid and Myeloid Dendritic Cell Development from CD34+ Hematopoietic Progenitor Cells
- (2013) Soley Thordardottir et al. STEM CELLS AND DEVELOPMENT
- Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network
- (2013) Till S. M. Manuel Mathan et al. Frontiers in Immunology
- Fusions between dendritic cells and whole tumor cells as anticancer vaccines
- (2013) Shigeo Koido et al. OncoImmunology
- The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
- (2012) G. Schreibelt et al. BLOOD
- Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells
- (2012) B. Chatterjee et al. BLOOD
- Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes
- (2012) Ines Moeller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34+ stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin
- (2012) AI Proietto et al. Cellular & Molecular Immunology
- Dendritic Cells Ameliorate Autoimmunity in the CNS by Controlling the Homeostasis of PD-1 Receptor+ Regulatory T Cells
- (2012) Nir Yogev et al. IMMUNITY
- F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells
- (2012) Susan Ahrens et al. IMMUNITY
- Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes
- (2012) Vincenzo Russo et al. INTERNATIONAL JOURNAL OF CANCER
- The mannose receptor
- (2012) Luisa Martinez-Pomares JOURNAL OF LEUKOCYTE BIOLOGY
- Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity
- (2012) Martin Kreutz et al. PLoS One
- Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo
- (2012) T. Fukaya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
- (2012) Dirk J. Reitsma et al. Human Vaccines & Immunotherapeutics
- Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation
- (2011) P. J. Tacken et al. BLOOD
- Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
- (2011) Manfred Brigl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype
- (2011) M. H. Lahoud et al. JOURNAL OF IMMUNOLOGY
- Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
- (2011) Paul J. Tacken et al. SEMINARS IN IMMUNOLOGY
- SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens
- (2010) S. Mukhopadhyay et al. BLOOD
- Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
- (2010) E. Klechevsky et al. BLOOD
- Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody
- (2010) C. Cheong et al. BLOOD
- Cancer Vaccine by Fusions of Dendritic and Cancer Cells
- (2010) Shigeo Koido et al. Clinical & Developmental Immunology
- Tonic T cell signalling and T cell tolerance as opposite effects of self-recognition on dendritic cells
- (2010) Natalio Garbi et al. CURRENT OPINION IN IMMUNOLOGY
- Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities
- (2010) R. T. Lee et al. GLYCOBIOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+cells as homologues of mouse CD8+dendritic cells
- (2010) Annabell Bachem et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of human DNGR-1+BDCA3+leukocytes as putative equivalents of mouse CD8α+dendritic cells
- (2010) Lionel Franz Poulin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells
- (2010) Céline Beauvillain et al. JOURNAL OF HEPATOLOGY
- Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
- (2010) T. Tsuji et al. JOURNAL OF IMMUNOLOGY
- Enhanced Generation of Cytotoxic T Lymphocytes by Heat Shock Protein 70 Fusion Proteins Harboring Both CD8+T Cell and CD4+T Cell Epitopes
- (2010) Seiji Takemoto et al. MOLECULAR PHARMACEUTICS
- Dendritic cells control T cell tonic signaling required for responsiveness to foreign antigen
- (2010) K. Hochweller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC-205/CD205 Receptor on Dendritic Cells
- (2009) Bei Wang et al. Annals of the New York Academy of Sciences
- Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia
- (2009) Koenraad Van Doorslaer et al. GYNECOLOGIC ONCOLOGY
- Directing dendritic cell immunotherapy towards successful cancer treatment
- (2009) Rachel Lubong Sabado et al. Immunotherapy
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- The C-Type Lectin Clec12A Present on Mouse and Human Dendritic Cells Can Serve as a Target for Antigen Delivery and Enhancement of Antibody Responses
- (2009) M. H. Lahoud et al. JOURNAL OF IMMUNOLOGY
- Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma
- (2009) Lisa H. Butterfield et al. JOURNAL OF IMMUNOTHERAPY
- CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self
- (2009) Rachel E. Shrimpton et al. MOLECULAR IMMUNOLOGY
- Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
- (2009) David Sancho et al. NATURE
- Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation
- (2009) R. Belizaire et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells
- (2009) A. Schildknecht et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HDL-Mimicking Peptide-Lipid Nanoparticles with Improved Tumor Targeting
- (2009) Zhihong Zhang et al. Small
- Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients
- (2008) R. Fontana et al. BLOOD
- The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
- (2008) I. Caminschi et al. BLOOD
- Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN- production
- (2008) F. Meyer-Wentrup et al. BLOOD
- Inhibition of Melanoma Growth by Targeting of Antigen to Dendritic Cells via an Anti-DEC-205 Single-Chain Fragment Variable Molecule
- (2008) T. S. Johnson et al. CLINICAL CANCER RESEARCH
- Human and murine model cell lines for dendritic cell biology evaluated
- (2008) Suzanne F.G. van Helden et al. IMMUNOLOGY LETTERS
- CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+Dendritic Cells and a Subset of Monocytes
- (2008) Cristal Huysamen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- “Dermal Dendritic Cells” Comprise Two Distinct Populations: CD1+ Dendritic Cells and CD209+ Macrophages
- (2008) Maria Teresa Ochoa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Human dendritic cell line models for DC differentiation and clinical DC vaccination studies
- (2008) Saskia J. A. M. Santegoets et al. JOURNAL OF LEUKOCYTE BIOLOGY
- DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production
- (2008) Friederike Meyer-Wentrup et al. JOURNAL OF LEUKOCYTE BIOLOGY
- In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
- (2008) Shigeo Koido et al. Journal of Translational Medicine
- Engineered lentivector targeting of dendritic cells for in vivo immunization
- (2008) Lili Yang et al. NATURE BIOTECHNOLOGY
- Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling
- (2008) Scott H Robbins et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now